Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Manfred Gossen, Heidelberg Bujard · Proceedings of the National Academy of Sciences · 1992 · 4.9K citations

Viral Replication, Molecular Regulation, Immunology +20

Cancer Statistics, 2001

Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text

Epidemiology Of Cancer, Health Disparities, Cancer Death +16

Cancer Statistics, 2002

Ahmedin Jemal, Anish Thomas, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2002 · 2.9K citations · Full text

American Cancer Society, Cancer Statistics, Epidemiology +12

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

Marc Dellian, Dai Fukumura, Michael Leunig et al. · PubMed · 1995 · 1.7K citations

Cutoff Size, Microvascular Permeability, Engineering +20

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

George N. Thalmann, Ploutarchos Anezinis, Shi Chang et al. · PubMed · 1994 · 739 citations

Urology, Oncology, Lncap Model +14